Patent application lodged for novel drug delivery system
Filed with ASX · · 3 pages · English
Story so far
Earlier from Argent Biopharma
- 1St patient recruited into CimetrA phase 3 clinical trial
- CannEpil available for free dispensing in ireland
- MGC pharma 2021 clinical trials program update
- CimetrA patent submitted to European IP office
- Further findings on ArtemiC as anti-inflammatory agent
Later from Argent Biopharma
- MGC pharma executes US$24M US supply agreement
- Cimetra import approval granted for india
- UK import permit granted for CannEpil
- ArtemiC eu sale approval and clinical trial update
- First order received under US supply agreement
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma